Claudia Mugnaini Selected Research

immucillin G

1/2019

Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: Preliminary in vitro studies with analogues of immucillin-G.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Mugnaini Research Topics

Disease

5	Pain (Aches) 01/2020 - 08/2008
2	COVID-19 03/2022 - 10/2021
2	Neuroinflammatory Diseases 01/2017 - 01/2016
2	Tuberculosis (Tuberculoses) 07/2013 - 01/2009
1	Bacterial Infections (Bacterial Infection) 05/2020
1	Osteoarthritis 01/2020
1	Joint Diseases (Joint Disease) 01/2020
1	Hyperuricemia 01/2019
1	Astrocytoma (Pilocytic Astrocytoma) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Glioma (Gliomas) 01/2019
1	Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Multiple Sclerosis 01/2017
1	Relapsing-Remitting Multiple Sclerosis 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Reperfusion Injury 12/2012
1	Ischemia 12/2012
1	Substance-Related Disorders (Drug Abuse) 03/2012
1	Cognitive Dysfunction 03/2012
1	Epilepsy (Aura) 03/2012
1	Anxiety Disorders (Anxiety Disorder) 03/2012
1	Infections 02/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2005

Drug/Important Bio-Agent (IBA)

4	CB2 Cannabinoid ReceptorIBA 01/2019 - 12/2012
4	N- (adamantan- 1- yl)- 4- oxo- 1- pentyl- 6- phenyl- 1,4- dihydroquinoline- 3- carboxamideIBA 01/2019 - 06/2012
3	CannabinoidsIBA 01/2020 - 01/2017
3	Formaldehyde (Formol)FDA Link 06/2012 - 08/2008
2	Pharmaceutical PreparationsIBA 03/2022 - 01/2019
2	Analgesics (Analgesic Drugs)IBA 08/2010 - 08/2008
1	LigandsIBA 03/2022
1	SARS-CoV-2 3C-like proteinaseIBA 10/2021
1	Nelfinavir (Viracept)FDA Link 10/2021
1	VaccinesIBA 10/2021
1	Ritonavir (Norvir)FDA Link 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2020
1	Iodoacetic AcidIBA 01/2020
1	immucillin GIBA 01/2019
1	Allopurinol (Remid)FDA LinkGeneric 01/2019
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	Xanthine DehydrogenaseIBA 01/2019
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2019
1	HypoxanthineIBA 01/2019
1	XanthineIBA 01/2019
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2019
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2019
1	Myelin Basic ProteinIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Levofloxacin (Levaquin)FDA Link 07/2013
1	Ciprofloxacin (Cipro)FDA LinkGeneric 07/2013
1	4-quinolone-3-carboxylic acidIBA 12/2012
1	GABA-B Receptor AgonistsIBA 03/2012
1	FluoroquinolonesIBA 01/2009
1	SolutionsIBA 02/2007

Therapy/Procedure

2	Therapeutics 10/2021 - 01/2019
1	Drug Therapy (Chemotherapy) 08/2005